Genentech 322017 CD20 Multiple sclerosis 761063 02620 m 10y192016 fully homan PDGFRA 761038 Genentech 620203 IgE 1097 6/19/1998 10377 927206 fully human EGFR 12514n Merck 942D14 PD-1 682012 HER2 EL LUly 4212014 tul hama VEGFR2 125477 6302006 VECPR 12515 2242012 fully hama 12534 Teva 3232016 Severe asthma 76103 126197 Hodgkin 1/21/2015 subcv fully heman IL17A 125504 Janssea Biotech 4232014 chimeric 12549 1a2010 6 12527 0212013 Herceptia tech 925/1938 HER2 10379 9252009 fully homan 12526 anssen Biotech 9232016 fully human Ctoba's disease mab 5s202014naw humanized 123476 ults in clinical trials.In April 2009.the Economics Since 2000.the the ally The h mab (both o and n20 of the 20 2 rapid grow See also .Antigen 5T4